Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

О Lite Strategy

Основано

2018

Сообщество

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Подробности сбора средств

Раунд финансированияСуммаОценка
Date
Инвесторы
Post-IPO
₽8.46B
--
2025-07-21
--